Extravillous trophoblast

From WikiMD's WELLNESSPEDIA

Extravillous Trophoblast (EVT) is a specialized type of cell that plays a crucial role in the process of placentation, the formation and function of the placenta. These cells originate from the trophoblast, a layer of cells surrounding the early embryo that will eventually form the placenta, an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, waste elimination, and gas exchange via the mother's blood supply.

Function[edit]

The primary function of the EVT is to invade the maternal endometrium (the inner lining of the uterus) and its blood vessels. This invasion is essential for the remodeling of maternal spiral arteries, transforming them into large conduits of blood that are necessary to supply the growing fetus with adequate nutrients and oxygen. EVTs migrate into the maternal myometrium (the muscular layer of the uterus) and contribute to the establishment of a successful pregnancy by facilitating the exchange of gases, nutrients, and waste products between the mother and the fetus.

Types of Extravillous Trophoblasts[edit]

There are two main types of EVTs: interstitial EVTs, which invade the uterine stroma, and endovascular EVTs, which invade the walls of maternal vessels. Both types play a critical role in the modification of maternal spiral arteries and the establishment of the uteroplacental circulation.

Pathology[edit]

Abnormal EVT function or inadequate invasion of the maternal endometrium can lead to pregnancy-related complications such as pre-eclampsia, fetal growth restriction, and placental abruption. These conditions can have significant impacts on both maternal and fetal health, highlighting the importance of EVT in pregnancy.

Research and Clinical Significance[edit]

Understanding the mechanisms controlling EVT invasion and function has been a significant focus of reproductive biology research. Insights into these processes are crucial for developing therapeutic strategies to manage pregnancy complications associated with abnormal placental development and function.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.